Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Dynamin 1 Antikörper (AA 616-667) (DyLight 550)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Dynamin 1 in FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7354731

Kurzübersicht für Dynamin 1 Antikörper (AA 616-667) (DyLight 550) (ABIN7354731)

Target

Alle Dynamin 1 (DNM1) Antikörper anzeigen
Dynamin 1 (DNM1)

Reaktivität

  • 103
  • 46
  • 44
  • 11
  • 9
  • 9
  • 3
  • 2
  • 2
  • 2
  • 1
Human

Wirt

  • 93
  • 11
  • 4
Kaninchen

Klonalität

  • 103
  • 6
Polyklonal

Konjugat

  • 55
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Dynamin 1 Antikörper ist konjugiert mit DyLight 550

Applikation

  • 93
  • 39
  • 39
  • 36
  • 25
  • 14
  • 13
  • 8
  • 7
  • 4
  • 3
  • 1
  • 1
Flow Cytometry (FACS)
  • Bindungsspezifität

    • 32
    • 22
    • 15
    • 6
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 616-667

    Verwendungszweck

    Anti-Human Dynamin 1 DyLight® 550 conjugated DNM1 Antibody

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins.

    Produktmerkmale

    Anti-Human Dynamin 1 DyLight® 550 conjugated DNM1 Antibody -Dyl550. Tested in Flow Cytometry applications. This antibody reacts with Human.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    E. coli-derived human Dynamin 1 recombinant protein (Position: W616-D667).

    Isotyp

    IgG
  • Applikationshinweise

    Flow Cytometry (Fixed), 1-3 μg/1x106 cells1. Dhindsa, R. S., Bradrick, S. S., Yao, X., Heinzen, E. L., Petrovski, S., Krueger, B. J., Johnson, M. R., Frankel, W. N., Petrou, S., Boumil, R. M., Goldstein, D. B. Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis. Neurol. Genet. 1: e4, 2015. 2. EuroEPINOMICS-RES Consortium, Epilepsy Phenome/Genome Project, Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am. J. Hum. Genet. 95: 360-370, 2014.

    Kommentare

    Other applications have not been tested. Optimal dilutions should be determined by end users.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    Lot specific

    Buffer

    Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
  • Target

    Dynamin 1 (DNM1)

    Andere Bezeichnung

    DNM1

    Hintergrund

    Synonyms: Dynamin-1, DNM1, DNM

    Background: Dynamin-1 is a protein that in humans is encoded by the DNM1 gene. This gene encodes a member of the dynamin subfamily of GTP-binding proteins. The encoded protein possesses unique mechanochemical properties used to tubulate and sever membranes, and is involved in clathrin-mediated endocytosis and other vesicular trafficking processes. Actin and other cytoskeletal proteins act as binding partners for the encoded protein, which can also self-assemble leading to stimulation of GTPase activity. More than sixty highly conserved copies of the 3' region of this gene are found elsewhere in the genome, particularly on chromosomes Y and 15. Alternatively spliced transcript variants encoding different isoforms have been described.

    Molekulargewicht

    39 kDa

    Gen-ID

    1759

    UniProt

    Q05193

    Pathways

    Toll-Like Receptors Cascades, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling
Sie sind hier:
Chat with us!